Are you Dr. Wu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 17 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
400 NE Mother Joseph Pl
Vancouver, WA 98664Phone+1 360-514-2116- Is this information wrong?
Summary
- Dr. Yaping Wu, MD is a board certified pathologist in Vancouver, Washington. He is currently licensed to practice medicine in Washington, Oregon, and California. He is affiliated with Providence Portland Medical Center, Providence St. Vincent Medical Center, and Providence Milwaukie Hospital.
Education & Training
- City of Hope National Medical CenterFellowship, Hematopathology, 2003 - 2004
- University of Kansas School of MedicineResidency, Pathology-Anatomic and Clinical, 1999 - 2002
- Chongqing Medical UniversityClass of 1983
Certifications & Licensure
- CA State Medical License 2003 - Present
- OR State Medical License 2007 - 2025
- WA State Medical License 2005 - 2009
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.David B Page, Joanna Pucilowska, Brie Chun, Isaac Kim, Katherine Sanchez, Nicole Moxon, Staci Mellinger, Yaping Wu, Yoshinobu Koguchi, Valerie Conrad, William L Redmon...> ;NPJ Breast Cancer. 2023 Jun 21
- 24 citationsGalunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.Tomoko Yamazaki, Andrew J Gunderson, Miranda Gilchrist, Mark Whiteford, Maria X Kiely, Amanda Hayman, David O'Brien, Rehan Ahmad, Jeffrey V Manchio, Nathaniel Fox, Kay...> ;The Lancet. Oncology. 2022 Sep 1
- 8 citationsClinical utility of PDX cohorts to reveal biomarkers of intrinsic resistance and clonal architecture changes underlying acquired resistance to cetuximab in HNSCC.Yanli Yao, Yujue Wang, Lan Chen, Zhen Tian, Guizhu Yang, Rui Wang, Chong Wang, Qi Wu, Yaping Wu, Jiamin Gao, Xindan Kang, Shengzhong Duan, Zhiyuan Zhang, Shuyang Sun> ;Signal Transduction and Targeted Therapy. 2022 Mar 8
- Join now to see all
Hospital Affiliations
- Providence Milwaukie HospitalPortland, Oregon
- Providence Portland Medical CenterPortland, Oregon
- Providence St. Vincent Medical CenterPortland, Oregon
- Providence Medford Medical CenterMedford, Oregon
- Providence Willamette Falls Medical CenterOregon City, Oregon
- Providence Hood River Memorial HospitalHood River, Oregon
- Providence Seaside HospitalSeaside, Oregon
- Providence Newberg Medical CenterNewberg, Oregon